Cargando…

Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa)

BACKGROUND: We aimed to directly compare results from multi-parametric prostate MRI (mpMRI) and a biopsy-based 17-gene RT-PCR assay providing a Genomic Prostate Score (GPS) among individuals who were candidates for active surveillance with low and intermediate risk prostate cancer (PCa). PATIENTS AN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leapman, Michael S., Westphalen, Antonio C., Ameli, Niloufar, Lawrence, H. Jeffrey, Febbo, Phillip G., Cooperberg, Matthew R., Carroll, Peter R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634556/ https://www.ncbi.nlm.nih.gov/pubmed/29016610 http://dx.doi.org/10.1371/journal.pone.0185535

Ejemplares similares

The 17-gene Genomic Prostate Score assay as a predictor of biochemical recurrence in men with intermediate and high-risk prostate cancer
por: Helfand, Brian T., et al.
Publicado: (2022)

The Prostate Health Index aids multi-parametric MRI in diagnosing significant prostate cancer
por: Fan, Yu-Hua, et al.
Publicado: (2021)

Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)
por: Stephan, Carsten, et al.
Publicado: (2014)

Clinically significant prostate cancer (csPCa) detection with various prostate sampling schemes based on different csPCa definitions
por: Wang, Fei, et al.
Publicado: (2021)

A vision for closing the evidence-practice gap in the management of low-grade prostate cancer
por: Leapman, Michael S, et al.
Publicado: (2023)

A modeling study to estimate prostate cancer‐specific mortality on active surveillance for men with favorable intermediate‐risk prostate cancer: Results from the SEARCH cohort
por: Kuhlmann, Paige K., et al.
Publicado: (2023)

MRI for managing intermediate & low risk prostate cancer
por: Padhani, Anwar R
Publicado: (2014)

PROMIS — Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer()
por: El-Shater Bosaily, A., et al.
Publicado: (2015)

Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivo
por: Oltean, Sebastian, et al.
Publicado: (2008)

Extraction of Prostatic Lumina and Automated Recognition for Prostatic Calculus Image Using PCA-SVM
por: Wang, Zhuocai, et al.
Publicado: (2011)

Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy
por: Rubio-Briones, Jose, et al.
Publicado: (2015)

Multi-parametric MRI imaging of the prostate—implications for focal therapy
por: Wysock, James S., et al.
Publicado: (2017)

False positive and false negative diagnoses of prostate cancer at multi-parametric prostate MRI in active surveillance
por: Quon, Jeffrey S., et al.
Publicado: (2015)

Addressing image misalignments in multi-parametric prostate MRI for enhanced computer-aided diagnosis of prostate cancer
por: Kovacs, Balint, et al.
Publicado: (2023)

The Within-Group Discrimination Ability of the Cancer of the Prostate Risk Assessment Score for Men with Intermediate-Risk Prostate Cancer
por: Kang, Ho Won, et al.
Publicado: (2017)

Differences in negative predictive value of prostate MRI based in men with suspected or known cancer
por: Baghdanian, Armonde A., et al.
Publicado: (2019)

Urinary PCA3 a Superior Diagnostic Biomarker for Prostate Cancer among Ghanaian Men
por: Opoku Mensah, Bismark, et al.
Publicado: (2022)

Incorporating Oxygen-Enhanced MRI into Multi-Parametric Assessment of Human Prostate Cancer
por: Zhou, Heling, et al.
Publicado: (2017)

The Prostate Health Index and multi-parametric MRI improve diagnostic accuracy of detecting prostate cancer in Asian populations
por: Ye, Changhee, et al.
Publicado: (2022)

Stability of Multi-Parametric Prostate MRI Radiomic Features to Variations in Segmentation
por: Thulasi Seetha, Sithin, et al.
Publicado: (2023)

The use of prostate MR for targeting prostate biopsies
por: Kelley, R. Phelps, et al.
Publicado: (2019)

β-catenin as a prognostic factor for prostate cancer (PCa)
por: Nowicki, Andrzej, et al.
Publicado: (2012)

MultiParametric Magnetic Resonance Imaging-Based Nomogram for Predicting Prostate Cancer and Clinically Significant Prostate Cancer in Men Undergoing Repeat Prostate Biopsy
por: Huang, Cong, et al.
Publicado: (2018)

Barriers to obtaining prostate multi‐parametric magnetic resonance imaging in African‐American men on active surveillance for prostate cancer
por: Walton, Eric L., et al.
Publicado: (2019)

Therapy decisions after diagnosis of prostate cancer in men with negative prostate MRI
por: Schmid, Florian A., et al.
Publicado: (2022)

Impact of the integration of proton magnetic resonance imaging spectroscopy to PI-RADS 2 for prediction of high grade and high stage prostate cancer
por: Leapman, Michael S., et al.
Publicado: (2017)

King’s Health Partners’ Prostate Cancer Biobank (KHP PCaBB)
por: Saifuddin, S. R., et al.
Publicado: (2017)

Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS)
por: Newcomb, Lisa F., et al.
Publicado: (2019)

The Relative Impact of Urinary and Sexual Function vs Bother on Health Utility for Men With Prostate Cancer
por: Jeong, Chang Wook, et al.
Publicado: (2020)

Prediction of Prostate Cancer Disease Aggressiveness Using Bi-Parametric Mri Radiomics
por: Rodrigues, Ana, et al.
Publicado: (2021)

Multi-parametric MRI of the prostate: Factors predicting extracapsular extension at the time of radical prostatectomy
por: Gaunay, Geoffrey S., et al.
Publicado: (2017)

Effectiveness of Bi-Parametric MR/US Fusion Biopsy for Detecting Clinically Significant Prostate Cancer in Prostate Biopsy Naïve Men
por: Kim, Young Joo, et al.
Publicado: (2019)

The Prostate Health Index adds predictive value to multi-parametric MRI in detecting significant prostate cancers in a repeat biopsy population
por: Gnanapragasam, V. J., et al.
Publicado: (2016)

Modified Prostate Health Index Density Significantly Improves Clinically Significant Prostate Cancer (csPCa) Detection
por: Chen, Haojie, et al.
Publicado: (2022)

Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells
por: Jeet, Varinder, et al.
Publicado: (2014)

PCA3 and PCA3-Based Nomograms Improve Diagnostic Accuracy in Patients Undergoing First Prostate Biopsy
por: Ruffion, Alain, et al.
Publicado: (2013)

Optimal MRI sequences for (68)Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer
por: Lake, Spencer T., et al.
Publicado: (2017)

Identification of Plasma Glycosphingolipids as Potential Biomarkers for Prostate Cancer (PCa) Status
por: Snider, Ashley J., et al.
Publicado: (2020)

An overview of prostate cancer (PCa) diagnosis: Potential role of miRNAs
por: Bilal, Muhammad, et al.
Publicado: (2022)

Genomic biomarkers in prostate cancer
por: Kornberg, Zachary, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7754t51935i87hsguukmuhplhh